DOJ Announces Money-Laundering Charge Tied to Alleged $1.3 Billion Health-Care Fraud Scheme

The Justice Department announced Friday that a federal grand jury in Boston had returned an indictment charging Erekle Gugava, 33, with one count of money-laundering conspiracy. Prosecutors tied the charge to an alleged health-care fraud scheme involving ND Medical Solutions LLC, a Pennsylvania durable medical equipment company that they say submitted at least $1.3 billion in fraudulent claims.

The $1.3 billion figure refers to claims allegedly submitted to insurers, not money that prosecutors say was actually paid out. According to the Justice Department, Medicare and other health insurers paid ND Medical about $6.5 million during the period at issue. The indictment is an allegation, and Gugava is presumed innocent unless proven guilty beyond a reasonable doubt.

DOJ said in its September 4 announcement that the grand jury returned the indictment a day earlier. The department also said Gugava fled the United States in July 2025 after the alleged conduct. The release did not identify a scheduled initial court appearance.

ND Medical allegedly billed $1.3 billion in five months

Prosecutors allege that Gugava purportedly owned ND Medical between February and July 2025. In that five-month period, the company allegedly submitted fraudulent durable medical equipment claims to Medicare, private insurers that provided Medicare supplemental coverage, employer-sponsored health plans and union health plans.

The scale of the submitted claims is central to the case, but the difference between billings and payments is equally important. DOJ says the insurers paid ND Medical approximately $6.5 million, a small fraction of the $1.3 billion in claims the company allegedly filed. That distinction separates the alleged attempted billing volume from the amount of insurance money that prosecutors say reached the company.

Charging documents also describe the use of stolen identities to support the billings. DOJ said identities belonging to people in Massachusetts, elsewhere in New England and across the United States were used in the alleged scheme. Some elderly and disabled people contacted Medicare or its contractors after receiving explanation-of-benefits notices for equipment they said they never received, prescriptions from doctors they had never visited and claims associated with ND Medical, a supplier they did not recognize.

Those allegations place the ND Medical activity within Operation Gold Rush, an investigation into a foreign-based organization that prosecutors say obtained control of medical-supply companies and used them to submit large volumes of claims. Gugava’s September indictment, however, charges him specifically with money-laundering conspiracy rather than announcing a separate substantive health-care fraud count against him.

Prosecutors focus on movement of insurer payments

The money-laundering allegation centers on what happened after insurers issued payments. DOJ says Gugava opened several bank accounts in ND Medical’s name and was the sole signatory on those accounts. Prosecutors allege that checks from Medicare supplemental insurers and other health insurers were deposited into the accounts before funds were ultimately transferred to overseas bank accounts for the benefit of the organization.

According to the department, the source of the payments made the alleged laundering activity harder to distinguish from ordinary business receipts. The money came from Medicare and established private insurance carriers, so the deposits initially appeared to originate from legitimate counterparties even though prosecutors contend the underlying claims were fraudulent.

That mechanism is a recurring feature of the wider Operation Gold Rush allegations. Prosecutors have said the organization used medical-equipment companies, bank accounts and overseas transfers to move insurance proceeds while attempting to conceal who actually controlled the companies and where the money was going. The September 4 case narrows that broader theory to the accounts and payments tied to ND Medical and to Gugava’s alleged role in handling them.

A conviction on the money-laundering conspiracy charge can carry a maximum sentence of 20 years in prison. The U.S. Attorney’s Office for Massachusetts also said the charge carries up to three years of supervised release and a fine of as much as $500,000 or twice the amount of laundered funds, whichever is greater. Any sentence would be determined by a federal judge under the applicable statutes and sentencing guidelines.

Operation Gold Rush has expanded since the original 2025 charges

Operation Gold Rush was publicly unveiled in June 2025 as part of a national health-care fraud enforcement action. In the original cases, DOJ alleged that a transnational organization based in Russia and elsewhere acquired dozens of durable medical equipment companies, installed nominee owners and used stolen personal information belonging to more than one million Americans to submit fraudulent Medicare claims.

More than $10.6 billion in fraudulent Medicare claims for durable medical equipment were attributed to the organization by DOJ. Most of those claims were blocked before payment, according to DOJ, but the government estimated that scheme companies still received nearly $900 million from Medicare supplemental insurers and about $41 million from Medicare. Authorities had seized approximately $27.7 million in alleged fraud proceeds by the time the original 2025 charges were announced.

Within that wider enforcement effort, the $1.3 billion in claims attributed to ND Medical should not be treated as an additional amount on top of every previously announced Gold Rush figure without knowing how the government aggregates the underlying claims. DOJ describes Gugava as a money launderer for the same foreign-based organization and says the company he purportedly owned was used during a concentrated five-month period in 2025.

By August 14, 2026, DOJ said 35 people had been charged as part of Operation Gold Rush and 16 had been convicted. That update came when an Ohio man pleaded guilty to laundering about $3.4 million in health-care fraud proceeds through regional banks on behalf of the same organization.

Investigators on the Gugava case include HHS-OIG, the FBI, the U.S. Postal Inspection Service, IRS Criminal Investigation, Homeland Security Investigations and the Labor Department’s Employee Benefits Security Administration. DOJ’s September 4 release did not announce a court date for Gugava, and the department said he had left the United States in July 2025. Until the charge is resolved in court, the allegations remain unproven.